BEHAVIORAL PHARMACOLOGICAL PROFILE OF CGS-9895 - A NOVEL ANXIOMODULATOR WITH SELECTIVE BENZODIAZEPINE AGONIST AND ANTAGONIST PROPERTIES

被引:29
|
作者
BENNETT, DA
AMRICK, CL
WILSON, DE
BERNARD, PS
YOKOYAMA, N
LIEBMAN, JM
机构
关键词
D O I
10.1002/ddr.430060404
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:313 / 325
页数:13
相关论文
共 50 条
  • [41] Biochemical and pharmacological properties of ASP1645, a novel selective P2Y12 receptor antagonist
    Uemura, T.
    Kawasaki, T.
    Moritani, Y.
    Sakata, C.
    Takamura, F.
    Takasaki, J.
    Koga, Y.
    Ito, H.
    Mutoh, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 945 - 945
  • [42] PHARMACOLOGICAL PROFILE OF SK-AND-F-104353 - A NOVEL, POTENT AND SELECTIVE PEPTIDOLEUKOTRIENE RECEPTOR ANTAGONIST IN GUINEA-PIG AND HUMAN AIRWAYS
    HAY, DWP
    MUCCITELLI, RM
    TUCKER, SS
    VICKERYCLARK, LM
    WILSON, KA
    GLEASON, JG
    HALL, RF
    WASSERMAN, MA
    TORPHY, TJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 243 (02): : 474 - 481
  • [43] PHARMACOLOGICAL PROFILE OF KBP-5074, A NOVEL NON STEROIDAL, HIGHLY SELECTIVE, MINERALOCORTICOID RECEPTOR ANTAGONIST (NIRA) FOR THE TREATMENT OF CARDIORENAL DISEASES
    Zhang, B.
    Tan, X. J.
    Wang, Y. L.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : A118 - A118
  • [44] PHARMACOLOGICAL PROFILE OF (-)HT-90B, A NOVEL 5-HT1A RECEPTOR AGONIST 5-HT2 RECEPTOR ANTAGONIST
    UCHIDA, H
    INAGAWA, K
    TAMEDA, C
    MIYAUCHI, T
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1995, 19 (07): : 1201 - 1216
  • [45] Pharmacological profile of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist atypical antipsychotic
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszlovszky, I.
    Horvath, A.
    Laszy, J.
    Schmidt, E.
    Szabo, G.
    Domany, G.
    Csongor, E. Agai
    Tihanyi, K.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S432 - S432
  • [46] Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y1 receptor antagonist
    Antal-Zimanyi, Ildiko
    Bruce, Marc. A.
    LeBoulluec, Karen L.
    Iben, Lawrence G.
    Mattson, Gail K.
    McGovern, Rachel T.
    Hogan, John B.
    Leahy, Christina L.
    Flowers, Sharon C.
    Stanley, Jennifer A.
    Ortiz, Astrid A.
    Poindexter, Graham S.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 590 (1-3) : 224 - 232
  • [47] RP-62203, A NAPHTOSULTAM DERIVATIVE WITH POTENT AND SELECTIVE 5-HT2 ANTAGONIST PROPERTIES .2. BEHAVIORAL PROFILE
    PIOT, O
    STUTZMANN, JM
    BLANCHARD, JC
    LADURON, PM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) : 1959 - 1960
  • [48] PHARMACOLOGICAL PROFILE OF AD-5423, A NOVEL ANTIPSYCHOTIC WITH BOTH POTENT DOPAMINE-D2 AND SEROTONIN-S2 ANTAGONIST PROPERTIES
    OKA, M
    NODA, Y
    OCHI, Y
    FURUKAWA, K
    UNE, T
    KURUMIYA, S
    HINO, K
    KARASAWA, T
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 264 (01): : 158 - 165
  • [49] Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M3 Receptor Antagonist/β2-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety Profile
    Aparici, Monica
    Carcasona, Carla
    Ramos, Israel
    Luis Montero, Jose
    Otal, Raquel
    Luis Ortiz, Jose
    Cortijo, Julio
    Puig, Carlos
    Vilella, Dolors
    De Alba, Jorge
    Doe, Chris
    Gavalda, Amadeu
    Miralpeix, Montserrat
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 370 (01): : 127 - 136
  • [50] Comparative Pharmacological Profile Of Las190792 And Las191351: Two Novel Bifunctional M3-Antagonist / β2-Agonist (maba) Molecules With A Different Balance Of Activities
    Aparici, M.
    Carcasona, C.
    Ramos, I.
    Puig, C.
    Vilella, D.
    Gavalda, A.
    Miralpeix, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189